Crossmark

Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade

Crossref DOI link: https://doi.org/10.1007/s11605-018-3745-6

Published Print: 2018-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Matsushima, Hajime https://orcid.org/0000-0002-1577-6587
Takami, Yuko

Ryu, Tomoki

Yoshitomi, Munehiro

Tateishi, Masaki

Wada, Yoshiyuki

Saitsu, Hideki
License Information

Text and Data Mining valid from 2018-07-01
More Information

This article is maintained by: Elsevier

Article Title: Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade

Journal Title: Journal of Gastrointestinal Surgery

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s11605-018-3745-6

Content Type: article

Copyright: Copyright © 2018 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.